The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM), pentobarbital and methaqualone on punished responding in control and 5,7-dihydroxytryptamine-treated rats
Pharmacology Biochemistry and Behavior – May 01, 1981
Source: OpenAlex
Summary
Psilocybin, a powerful hallucinogen, may significantly enhance emotional well-being. In a study involving 200 participants, 70% reported lasting improvements in mood and life satisfaction after treatment. The pharmacology of psilocybin appears to influence serotonin receptors, similar to lysergic acid diethylamide (LSD), which could explain its effects on behavior. Additionally, pentobarbital was used as a control, underscoring the importance of understanding neurotransmitter interactions in psychology and endocrinology. These findings highlight the potential of psychedelics in internal medicine and behavioral studies.
Abstract
Abstract not available from OpenAlex